Publications by authors named "Om Ganda"

Claim this Profile
A
Adherence to Lipid-Lowering Therapies and Cardiovascular Outcomes in Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis.
Laney K Jones, Cara East, Om P Ganda, Michael R Gionfriddo

J Am Heart Assoc· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of product label vs real-world safety data from branded icosapent ethyl users: A select analysis utilizing MarketScan data.
John R Nelson, Richard A Hansen, Handrean Soran, Nilima Justice, Om P Ganda

J Clin Lipidol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Lipid and ASCVD-Modulating Agents on Glycemia and New-Onset Diabetes or Prediabetes.
Om P Ganda

JACC Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-Sectional analysis of demographic and clinical characteristics of patients in the United States using icosapent ethyl.
Peter P Toth, John R Nelson, Handrean Soran, Om P Ganda, Nathan D Wong

Front Cardiovasc Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease.
Om P Ganda

Curr Opin Lipidol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes in ageing: pathways for developing the evidence base for clinical guidance.
Medha N Munshi, Graydon S Meneilly, Leocadio Rodríguez-Mañas, Kelly L Close, Paul R Conlin, Om P Ganda

Lancet Diabetes Endocrinol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When to lower triglycerides?
Om P Ganda

Curr Opin Lipidol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual responses to PCSK9 inhibitors in a clinical cohort utilizing a structured follow-up protocol.
Bruce A Warden, Joshua R Miles, Carlota Oleaga, Om P Ganda, P Barton Duell

Am J Prev Cardiol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of alirocumab among individuals with diabetes mellitus and atherosclerotic cardiovascular disease in the ODYSSEY phase 3 trials.
Om P Ganda, Jorge Plutzky, Santosh K Sanganalmath, Maja Bujas-Bobanovic, Andrew Koren

Diabetes Obes Metab· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond Statins: Who and When to Prescribe?
Om Ganda

Curr Diab Rep· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management.
Om P Ganda, Deepak L Bhatt, R Preston Mason, Michael Miller, William E Boden

J Am Coll Cardiol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From the editors: bringing the Joslin Clinical Guidelines to the diabetes care community.
Om P Ganda, Robert A Gabbay

Am J Manag Care· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Joslin Diabetes Center Clinical Oversight Committee.
Om P Ganda, Robert A Gabbay

Am J Manag Care· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHAPTER 1. Clinical guideline for adults with diabetes.
Samar Hafida, Om P Ganda, Robert A Gabbay,

Am J Manag Care· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHAPTER 2. Clinical nutrition guideline for overweight and obese adults with type 2 diabetes (T2D) or prediabetes, or those at high risk for developing T2D.
Osama Hamdy, Om P Ganda, Melinda Maryniuk, Robert A Gabbay,

Am J Manag Care· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHAPTER 3. Guideline for detection and management of diabetes in pregnancy.
Florence M Brown, Sue-Ellen Anderson-Haynes, Elizabeth Blair, Shanti Serdy, Elizabeth Halprin, Om P Ganda

Am J Manag Care· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHAPTER 4. Guideline for the care of the older adult with diabetes.
Medha Munshi, Elizabeth Blair, Om P Ganda, Robert A Gabbay,

Am J Manag Care· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHAPTER 5. Clinical guideline for pharmacological management of adults with type 2 diabetes.
Om P Ganda, Alissa Segal, Elizabeth Blair, Richard Beaser, Jason Gaglia

Am J Manag Care· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Consensus and Controversies in Guidelines for Lipid and Hypertension Management in Diabetes.
Om P Ganda, Joanna Mitri

Curr Cardiol Rep· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mHealth Intervention to Improve Diabetes Risk Behaviors in India: A Prospective, Parallel Group Cohort Study.
Angela Pfammatter, Bonnie Spring, Nalini Saligram, Raj Davé, Arun Gowda, Om Ganda

J Med Internet Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin-induced diabetes: incidence, mechanisms, and implications.
Om P Ganda

F1000Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antihyperglycemic drugs and cardiovascular outcomes in type 2 diabetes.
Om P Ganda

Cleve Clin J Med· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on Jakubowicz et al. Fasting Until Noon Triggers Increased Postprandial Hyperglycemia and Impaired Insulin Response After Lunch and Dinner in Individuals With Type 2 Diabetes: A Randomized Clinical Trial. Diabetes Care 2015;38:1820-1826.
Om P Ganda

Diabetes Care· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Failure to Report Financial Disclosure Information.
Om P Ganda

JAMA· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinician Understanding of Cholesterol Treatment Guidelines--Reply.
Om P Ganda

JAMA· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis